GEMCITABINE HETERO gemcitabine (as hydrochloride) 200 mg powder for injection vial

Страна: Австралия

Язык: английский

Источник: Department of Health (Therapeutic Goods Administration)

Активный ингредиент:

gemcitabine hydrochloride, Quantity: 228 mg

Доступна с:

Hetero Australia Pty Ltd

ИНН (Международная Имя):

Gemcitabine hydrochloride

Фармацевтическая форма:

Injection, powder for

состав:

Excipient Ingredients: sodium hydroxide; mannitol; sodium acetate trihydrate

Администрация маршрут:

Intravenous Infusion

Штук в упаковке:

1 vial

Тип рецепта:

(S4) Prescription Only Medicine

Терапевтические показания :

Gemcitabine is indicated for treatment of patients with locally advanced or metastatic non- small cell lung cancer.,Gemcitabine is indicated for treatment of patients with locally advanced or metastatic adenocarcinoma of the pancreas. Gemcitabine is also indicated for patients with 5-FU refractory pancreatic cancer.,Gemcitabine, alone or in combination with cisplatin, is indicated for treatment of patients with bladder cancer.,Gemcitabine, in combination with paclitaxel, is indicated for the treatment of patients with unresectable, locally recurrent or metastatic breast cancer who have relapsed following adjuvant/neoadjuvant chemotherapy. Prior chemotherapy should have included an anthracycline unless clinically contraindicated.,Gemcitabine, in combination with carboplatin, is indicated for the treatment of patients with recurrent epithelial ovarian carcinoma, who have relapsed > 6 months following platinum? based therapy

Обзор продуктов:

Visual Identification: White to off-white lyophilised powder to be reconstituted for intravenous use.; Container Type: Vial; Container Material: Glass Type I Clear; Container Life Time: 2 Years; Container Temperature: Store below 25 degrees Celsius

Статус Авторизация:

Licence status A

Дата Авторизация:

2015-03-03